Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational studyGiuseppe Buono, Grazia Arpino, Francesco Schettini et al.|Breast Cancer Research and Treatment|2020Cited by 70
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsAdriano Gravina, Federica Perrone, P. Gargiulo et al.|ESMO Open|2025Cited by 8